Thepaut Eric Francis Yves

Track

Insider profile

Performance

Overall performance
2.9
Performance over holding periods
2.9
30 days 90 days 120 days
Average return -2% 8.2% 15.1%
Success rate 63% 68% 82%
Transactions
7 0% Buy
34 71% Buy
47 69% Buy
Ranking by holding-period performance
Thepaut Eric Francis Yves's trades of Boston Scientific Corp's stock


• Purchase • Sale • Planned purchase • Planned sale Net purchase Net sale Buy signal Sell signal Earnings
Abbreviations B: Buy, S: Sell, PP: Planned purchase, PlS: Planned sale, PrS: Proposed sale, O: Option / Other
Transaction date
Proposed sale
Price
171.88
Quantity 57,037
Value US$2,033,342
Transaction date
Proposed sale
Price
52.49
Quantity 83,041
Value US$4,358,649
Transaction date
Sale
Price
40.99
Quantity 20,676 -22.2%
Value US$847,509
Notification date Transaction date Company B/S Transaction type Nb. shares
Price
Value 		Number of shares Price Value Details
2024-05-13 2024-05-10
S Sale
47,478 -5.1%
109.25
US$2,203,239 		47,478 -5.1% 109.25 US$2,203,239
2024-05-10 2024-05-10
PrS Proposed sale
57,037
171.88
US$2,033,342 		57,037 171.88 US$2,033,342
2023-05-03 2023-05-02
S Sale
93,496 +44.9%
401.15
US$4,474,452 		93,496 +44.9% 401.15 US$4,474,452
2023-05-02 2023-05-02
PrS Proposed sale
83,041
52.49
US$4,358,649 		83,041 52.49 US$4,358,649
2022-11-21 2022-11-18
S Sale
14,952 -20.6%
42.72
US$638,773 		14,952 -20.6% 42.72 US$638,773
2022-08-03 2022-08-01
S Sale
20,676 -22.2%
40.99
US$847,509 		20,676 -22.2% 40.99 US$847,509
2021-02-17 2021-02-12
PlS Planned sale
28,883 -28.9%
38.65
US$1,116,354 		28,883 -28.9% 38.65 US$1,116,354
2019-11-27 2019-11-26
S Sale
22,487 -22.7%
42.70
US$960,256 		22,487 -22.7% 42.70 US$960,256
2019-05-30 2019-05-29
S Sale
22,047 -19.9%
38.03
US$838,432 		22,047 -19.9% 38.03 US$838,432
2019-02-28 2019-02-27
S Sale
11,980 -9.8%
39.94
US$478,520 		11,980 -9.8% 39.94 US$478,520